Many synthetic cannabinoids were designed by Pfizer in the 1970s and 1980s, and feature an alphanumeric code beginning with the prefix "CP" (after Charles Pfizer). [1] Recently, several members of this class of cannabinoids have been discovered in recreational drug products. [2] [3] [4]